BIOMAT Database Logo BIOMAT Database Logo

Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH. 1994

E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Department of Clinical Chemistry, University Central Hospital of Turku, Finland.

We evaluated the ability of new thyrotropin (TSH) assays to separate hyperthyroid (n = 50) patients from clinically euthyroid subjects with low TSH values (nodular goiter, n = 20, and nonthyroidal illness, n = 22). Only patients whose serum TSH was < 0.1 mIU/L by immunoradiometric assay were included. We used a new immunofluorometric method based on time-resolved fluorescence (TR-IFMA) and a new immunochemiluminometric assay (ICMA) to measure TSH in serum. Although the differences between the hyperthyroid patients and the euthyroid patients differed from each other by both methods (P = 0.0012 for TR-IFMA and P < 0.0001 for ICMA), there was no cutoff point that could definitely separate the groups. Thus, it is not possible to draw any definite conclusions on whether a patient is hyperthyroid or not, solely on the basis of TSH concentration measured with these new TSH assays.

UI MeSH Term Description Entries
D006980 Hyperthyroidism Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE. Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006044 Goiter, Nodular An enlarged THYROID GLAND containing multiple nodules (THYROID NODULE), usually resulting from recurrent thyroid HYPERPLASIA and involution over many years to produce the irregular enlargement. Multinodular goiters may be nontoxic or may induce THYROTOXICOSIS. Nodular Goiter,Goiters, Nodular,Nodular Goiters
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly.
March 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3).
June 1974, The Journal of clinical endocrinology and metabolism,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Assessment of hemostasis in hyperthyroid and euthyroid cats using two viscoelastic assays and platelet aggregometry.
January 2024, Journal of veterinary internal medicine,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Two types of mitochondria in heart muscle from euthyroid and hyperthyroid rats.
February 1970, The Biochemical journal,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Transiently decreased sialylation of thyrotropin (TSH) in a patient with the euthyroid sick syndrome.
February 1997, Thyroid : official journal of the American Thyroid Association,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Low response of the thyroid gland to endogenous thyrotropin increased by thyrotropin-releasing hormone in patients with euthyroid Graves' disease.
October 1998, Thyroid : official journal of the American Thyroid Association,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Analytical evaluation of twenty assays for determination of thyrotropin (TSH).
January 1989, Annales de biologie clinique,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients.
August 1987, Clinical chemistry,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Serum thyrotropin (TSH) heterogeneity in euthyroid subjects and patients with subclinical hypothyroidism: the core fucose content of TSH-releasing hormone-released TSH is altered, but not the net charge of TSH.
March 1995, The Journal of endocrinology,
E Taimela, and R Tähtelä, and P Koskinen, and P Nuutila, and J Forsström, and S Taimela, and S L Karonen, and M Välimäki, and K Irjala
Deiodination of thyroxine by erythrocytes and leukocytes from euthyroid and hyperthyroid patients.
July 1969, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Copied contents to your clipboard!